In addition, we specifically focused on plasma cells alone using CD3−CD56−CD19low/midCD20−CD27hiCD138hi to avoid any complexity due to daratumumab-induced CD38 down-regulation as reported on MM cells [28]. This evidence concerns the gene CD38 and Miyoshi myopathy.